The Valley Desk

NCT02964338 · Interventional trial

A Study Comparing the Efficacy and Safety of Fremanezumab (TEV-48125) for the Prevention of Chronic Cluster Headache (CCH)

Overall registry status Terminated

Phase 3

Conditions Chronic Cluster Headache

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov